NDA for icotrokinra for the treatment of adults and adolescents 12 years of age and older with moderate to severe plaque ...

Meeting Completion Marks Major Step Toward Phase 3 AD04 Trial Launch Strategic Partnership Discussions Expected Following the ...

In August 2025, InSilico Medicine Hong Kong Limited announced a clinical trial is to learn about INS018_055 in adults with ...

A new study finds that cannabidiol (CBD) may offer relief from a common and challenging side effect of Parkinson’s treatment ...

Understanding exactly how psychedelics promote new connections in the brain is critical to developing targeted, ...

Through functional tests, researchers noted the major skink’s mutation is identical to the one that protects honey badgers ...